Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1976-7-6
|
| pubmed:abstractText |
A report is given from an on-going multicenter trial in Sweden, in which 117 hypertensive patients have been treated with a new cardioselective beta-adrenergic blocking agent, atenolol (ICI 66.082, Tenormin) for an average of six months (range 2-21). Statistically significant reductions of BP were observed, recumbent by 29/19 mmHg (p less than 0.0001) and standing by 28/18 mmHg (p less than 0.0001). Few and comparatively mild side-effects were seen.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0001-6101
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
199
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
257-61
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:4956-Adrenergic beta-Antagonists,
pubmed-meshheading:4956-Adult,
pubmed-meshheading:4956-Aged,
pubmed-meshheading:4956-Atenolol,
pubmed-meshheading:4956-Clinical Trials as Topic,
pubmed-meshheading:4956-Female,
pubmed-meshheading:4956-Humans,
pubmed-meshheading:4956-Hypertension,
pubmed-meshheading:4956-Male,
pubmed-meshheading:4956-Middle Aged,
pubmed-meshheading:4956-Propanolamines,
pubmed-meshheading:4956-Time Factors
|
| pubmed:year |
1976
|
| pubmed:articleTitle |
Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|